IDA Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

IDA Therapeutics General Information


Developer of immuno-diverse antibodies intended to treat a wide variety of cancers. The company leverages technology to develop antibodies to provide syngeneic models for in-vivo cancer therapy addressing tumor formation and metastases, enabling oncologists to better tackle ailments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1776 Yorktown Street
  • Suite 515
  • Houston, TX 77056
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IDA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Mar-2016 Completed Startup
To view IDA Therapeutics’s complete valuation and funding history, request access »

IDA Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
To view IDA Therapeutics’s complete investors history, request access »